The Department of Veterans Affairs recently announced that it will now require all covered drugs under the Veterans Health Care Act to be offered on Federal Supply Schedule contracts, regardless of whether they meet the "country of origin" standards of the Trade Agreements Act. This decision represents a major reversal in policy for the VA. The policy is being implemented immediately, requiring action for many companies as soon as April 26, 2016. For the first time, FSS contracts will now be open to hundreds of pharmaceutical products that are manufactured in non-TAA designated countries.
For more information on this topic, please click here.
This article is presented for informational purposes only and is not intended to constitute legal advice.